MediGene Concludes Agreement with Juste for the Commercialization of Veregen in Spain and Portugal
MediGene AG has entered into a marketing partnership with the Spanish company Juste S.A.Q.F. for the commercialization of Veregen ointment in Spain and Portugal. Juste, a family-owned specialty pharma company, will promote and distribute the drug for the treatment of genital warts. Depending on specified milestones and sales targets achieved, MediGene is entitled to successive payments totalling up to 2,550,000 euro. MediGene will supply Juste with the finished product, and will receive royalties on the sales revenue for Veregen. [more...]
|
|
|
